BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Looking Forward to a GREAT 2020, page-546

  1. 1,400 Posts.
    lightbulb Created with Sketch. 560
    Plenty and more Jalal, BOT' s antimicrobial program is also the flip side of BOT's anti-autoimmune program: as you know, a well articulated hypothesis for the 'pandemic' of autoimmune (and allergic) diseases sees the cause in the reduced exposure to microbes in early childhood.The so called 'hygiene hypothesis', based on strong evidence for a causal relationship between the decline of infections and the increase in immunological disorders.
    It's a darn good business model that BOT's setting up: selling the cure that kills the bugs and selling the cure for the incremental cases of autoimmune diseases (psoriasis and AD) caused by the killing of the bugs, it's a perpetual money-making loop.The guys at Goldman Sachs would love it and Vince would love to sing them the pitch when the time comes.

    All IMO, DYOR, no financial advice,....I'm posting cause I'm bored....etc,etc

    Last edited by aburbe: 24/02/20
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.